Palmitoylethanolamide-Incorporated Elastic Nano-Liposomes for Enhanced Transdermal Delivery and Anti-Inflammation

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2024 Jul 27

PMID 39065574

Authors

Chuanpeng Ren

Yanyun Ma

Yizhen Wang

Dan Luo

Yanhan Hong

Xinyuan Zhang

Hexiang Mei

Wei Liu

Affiliations

Soon will be listed here.

Abstract

Palmitoylethanolamide (PEA) exhibits multiple skincare functions such as anti-nociceptive and anti-inflammatory effects. However, its topical application is limited due to its difficulty in bypassing the barrier, relatively low bioavailability, and low stability. Herein, elastic nano-liposomes (ENLs) with excellent deformability and elasticity were utilized as a novel drug delivery system to encapsulate PEA to overcome the abovementioned issues and enhance the biological effects on the skin. ENL was prepared with phosphatidylcholine, cholesterol, and cetyl-PG hydroxyethyl palmitamide with a molar ratio mimicking skin epidermal lipids, and PEA was loaded. The PEA-loaded ENL (PEA-ENL) demonstrated efficient transdermal delivery and enhanced skin retention, with negligible cytotoxicity toward HaCaT cells and no allergic reaction in the human skin patch test. Notably, PEA-ENL treatment increased cell migration and induced significant regulation in the expression of genes associated with anti-nociceptive, anti-inflammatory, and skin barrier repair. The mechanism of the anti-nociceptive and anti-inflammatory effects of PEA was further investigated and explained by molecular docking site analysis. This novel PEA-ENL, with efficient transdermal delivery efficiency and multiple skincare functionalities, is promising for topical application.

Citing Articles

Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives.

Medoro A, Davinelli S, Fogacci F, Alfieri S, Tiso D, Cicero A Nutrients. 2025; 16(24.

PMID: 39770936 PMC: 11677032. DOI: 10.3390/nu16244313.

References

Verma D, Verma S, Blume G, Fahr A . Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003; 258(1-2):141-51. DOI: 10.1016/s0378-5173(03)00183-2. View

Cevc G, Schatzlein A, Richardsen H . Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 2002; 1564(1):21-30. DOI: 10.1016/s0005-2736(02)00401-7. View

Rankin L, Fowler C . The Basal Pharmacology of Palmitoylethanolamide. Int J Mol Sci. 2020; 21(21). PMC: 7662788. DOI: 10.3390/ijms21217942. View

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View

Chen J, Lu W, Gu W, Lu S, Chen Z, Cai B . Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv. 2013; 10(6):845-56. DOI: 10.1517/17425247.2013.779252. View

Andrei C, Zanfirescu A, Nitulescu G, Olaru O, Negres S . Natural Active Ingredients and TRPV1 Modulation: Focus on Key Chemical Moieties Involved in Ligand-Target Interaction. Plants (Basel). 2023; 12(2). PMC: 9860573. DOI: 10.3390/plants12020339. View

Citraro R, Russo E, Scicchitano F, van Rijn C, Cosco D, Avagliano C . Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology. 2012; 69:115-26. DOI: 10.1016/j.neuropharm.2012.11.017. View

Patzelt A, Mak W, Jung S, Knorr F, Meinke M, Richter H . Do nanoparticles have a future in dermal drug delivery?. J Control Release. 2016; 246:174-182. DOI: 10.1016/j.jconrel.2016.09.015. View

Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G . The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain. 2008; 139(3):541-550. DOI: 10.1016/j.pain.2008.06.003. View

10.

Gabrielsson L, Mattsson S, Fowler C . Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol. 2016; 82(4):932-42. PMC: 5094513. DOI: 10.1111/bcp.13020. View

11.

Beggiato S, Tomasini M, Ferraro L . Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease. Front Pharmacol. 2019; 10:821. PMC: 6667638. DOI: 10.3389/fphar.2019.00821. View

12.

Junaid Dar M, Din F, Khan G . Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug Deliv. 2018; 25(1):1595-1606. PMC: 6095017. DOI: 10.1080/10717544.2018.1494222. View

13.

Cosco D, Paolino D, Maiuolo J, Di Marzio L, Carafa M, Ventura C . Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery. Int J Pharm. 2015; 489(1-2):1-10. DOI: 10.1016/j.ijpharm.2015.04.056. View

14.

Ghasemiyeh P, Mohammadi-Samani S . Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages. Drug Des Devel Ther. 2020; 14:3271-3289. PMC: 7429187. DOI: 10.2147/DDDT.S264648. View

15.

Geusens B, Lambert J, De Smedt S, Buyens K, Sanders N, Van Gele M . Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes. J Control Release. 2008; 133(3):214-20. DOI: 10.1016/j.jconrel.2008.10.003. View

16.

Zhao Y, Schultz N, Truhlar D . Design of Density Functionals by Combining the Method of Constraint Satisfaction with Parametrization for Thermochemistry, Thermochemical Kinetics, and Noncovalent Interactions. J Chem Theory Comput. 2015; 2(2):364-82. DOI: 10.1021/ct0502763. View

17.

Akhtar N, Akhtar N, Menaa F, Alharbi W, Alaryani F, Alqahtani A . Fabrication of Ethosomes Containing Tocopherol Acetate to Enhance Transdermal Permeation: In Vitro and Ex Vivo Characterizations. Gels. 2022; 8(6). PMC: 9222905. DOI: 10.3390/gels8060335. View

18.

Bronzuoli M, Facchinetti R, Steardo Jr L, Romano A, Stecca C, Passarella S . Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: and Evidence. Oxid Med Cell Longev. 2018; 2018:4720532. PMC: 5822864. DOI: 10.1155/2018/4720532. View

19.

Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R . Palmitoylethanolamide: A Natural Compound for Health Management. Int J Mol Sci. 2021; 22(10). PMC: 8157570. DOI: 10.3390/ijms22105305. View

20.

Misery L, Loser K, Stander S . Sensitive skin. J Eur Acad Dermatol Venereol. 2016; 30 Suppl 1:2-8. DOI: 10.1111/jdv.13532. View